» Articles » PMID: 3016522

Differential Transformation of C3H10T1/2 Cells by V-mos: Sequential Expression of Transformation Parameters

Overview
Journal Mol Cell Biol
Specialty Cell Biology
Date 1985 Sep 1
PMID 3016522
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Extremely small quantities of the product of the transforming gene v-mos of Moloney murine sarcoma virus are able to efficiently transform cells. Recent data indicate the existence of a threshold level for v-mos transformation of NIH3T3 cells. Using mouse mammary tumor virus long terminal repeat sequences or hybrid promoters consisting of mouse mammary tumor virus and Moloney murine sarcoma virus long terminal repeat elements to express v-mos in C3H10T1/2 cells, we established cell lines representing different stages of morphological transformation in vitro. The threshold level for v-mos transformation was considerably lower than that for NIH3T3 cells, because no treatment with dexamethasone or primary selection other than transformation was necessary during standard transfection procedures. Using the cell lines mentioned we established an association of the level of v-mos expression with the transformation parameters examined, but not with p53 levels. Furthermore, the characterization of the different promoters showed (i) that the distal binding site confers hormone responsiveness to Moloney murine sarcoma virus promoter elements and (ii) that artifactual transcription initiation sites can be detected in mouse mammary tumor virus-Moloney murine sarcoma virus hybrid promoters which are, however, not regulated by the hormone.

Citing Articles

Transforming but not immortalizing oncogenes activate the transcription factor PEA1.

Wasylyk C, Imler J, Wasylyk B EMBO J. 1988; 7(8):2475-83.

PMID: 3142763 PMC: 457117. DOI: 10.1002/j.1460-2075.1988.tb03094.x.


The v-mos and H-ras oncogene expression represses glucocorticoid hormone-dependent transcription from the mouse mammary tumor virus LTR.

Jaggi R, Salmons B, Muellener D, Groner B EMBO J. 1986; 5(10):2609-16.

PMID: 3023051 PMC: 1167159. DOI: 10.1002/j.1460-2075.1986.tb04541.x.


Increased expression of the putative growth factor receptor p185HER2 causes transformation and tumorigenesis of NIH 3T3 cells.

Hudziak R, Schlessinger J, Ullrich A Proc Natl Acad Sci U S A. 1987; 84(20):7159-63.

PMID: 2890160 PMC: 299249. DOI: 10.1073/pnas.84.20.7159.


Use of a glucocorticoid-inducible promoter for expression of herpes simplex virus type 1 glycoprotein gC1, a cytotoxic protein in mammalian cells.

Friedman H, Yee A, DIGGELMANN H, Hastings J, Tal-Singer R, Eisenberg R Mol Cell Biol. 1989; 9(6):2303-14.

PMID: 2548078 PMC: 362303. DOI: 10.1128/mcb.9.6.2303-2314.1989.


The repressor sequence upstream of c-mos acts neither as polyadenylation site nor as transcription termination region.

van der Hoorn F, Neupert B Nucleic Acids Res. 1986; 14(22):8771-83.

PMID: 2431392 PMC: 311910. DOI: 10.1093/nar/14.22.8771.

References
1.
Buetti E, DIGGELMANN H . Glucocorticoid regulation of mouse mammary tumor virus: identification of a short essential DNA region. EMBO J. 1983; 2(8):1423-9. PMC: 555292. DOI: 10.1002/j.1460-2075.1983.tb01601.x. View

2.
Jakobovits E, Majors J, Varmus H . Hormonal regulation of the Rous sarcoma virus src gene via a heterologous promoter defines a threshold dose for cellular transformation. Cell. 1984; 38(3):757-65. DOI: 10.1016/0092-8674(84)90271-x. View

3.
Reznikoff C, Brankow D, HEIDELBERGER C . Establishment and characterization of a cloned line of C3H mouse embryo cells sensitive to postconfluence inhibition of division. Cancer Res. 1973; 33(12):3231-8. View

4.
Freedman V, Shin S . Cellular tumorigenicity in nude mice: correlation with cell growth in semi-solid medium. Cell. 1974; 3(4):355-9. DOI: 10.1016/0092-8674(74)90050-6. View

5.
HEIDELBERGER C . Chemical carcinogenesis. Annu Rev Biochem. 1975; 44:79-121. DOI: 10.1146/annurev.bi.44.070175.000455. View